These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 19611404)

  • 1. Prediction of antiepileptic drug efficacy: the use of intracerebral microdialysis to monitor biophase concentrations.
    Clinckers R; Smolders I; Vermoesen K; Michotte Y; Danhof M; Voskuyl R; Della Pasqua O
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1267-77. PubMed ID: 19611404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain.
    Clinckers R; Smolders I; Michotte Y; Ebinger G; Danhof M; Voskuyl RA; Della Pasqua O
    Br J Pharmacol; 2008 Dec; 155(7):1127-38. PubMed ID: 18836479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling.
    de Lange EC; Ravenstijn PG; Groenendaal D; van Steeg TJ
    AAPS J; 2005 Oct; 7(3):E532-43. PubMed ID: 16353931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
    Boström E; Hammarlund-Udenaes M; Simonsson US
    Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
    Bundgaard C; Jørgensen M; Larsen F
    Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity of antiepileptic drug targets.
    Beck H
    Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.
    Potschka H
    Adv Drug Deliv Rev; 2012 Jul; 64(10):943-52. PubMed ID: 22210135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood-brain barrier and epilepsy.
    Oby E; Janigro D
    Epilepsia; 2006 Nov; 47(11):1761-74. PubMed ID: 17116015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?
    Hammarlund-Udenaes M
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):215-20. PubMed ID: 20050843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs.
    Brunner M; Derendorf H; Müller M
    Curr Opin Pharmacol; 2005 Oct; 5(5):495-9. PubMed ID: 16084767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier.
    de Lange EC; Danhof M; de Boer AG; Breimer DD
    Brain Res Brain Res Rev; 1997 Sep; 25(1):27-49. PubMed ID: 9370049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental basis for the treatment of drug-resistant epilepsy].
    Błaszczyk B; Trojnar M; Czuczwar SJ
    Przegl Lek; 2006; 63(11):1221-3. PubMed ID: 17348421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of drug resistance in epilepsy].
    Lasoń W
    Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vitro cell models in predicting in vivo brain entry of drugs.
    Hakkarainen JJ; Jalkanen AJ; Kääriäinen TM; Keski-Rahkonen P; Venäläinen T; Hokkanen J; Mönkkönen J; Suhonen M; Forsberg MM
    Int J Pharm; 2010 Dec; 402(1-2):27-36. PubMed ID: 20920560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to assess drug permeability across the blood-brain barrier.
    Nicolazzo JA; Charman SA; Charman WN
    J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pharmacokinetic methods for the study of antiepileptic medications of the 1990s.
    Browne TR; Szabo GK
    Epilepsia; 1991; 32 Suppl 5():S66-73. PubMed ID: 1743172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy reviews: clinical pharmacology of antiepileptic drugs.
    Browne TR
    Am J Hosp Pharm; 1978 Sep; 35(9):1048-56. PubMed ID: 358830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.